Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Change in Accured Expenses (2023 - 2026)

Rallybio's Change in Accured Expenses history spans 3 years, with the latest figure at $33000.0 for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 102.37% to $33000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.1 million, a 65.64% increase, with the full-year FY2025 number at -$1.1 million, up 65.64% from a year prior.
  • Change in Accured Expenses hit $33000.0 in Q4 2025 for Rallybio, up from -$350000.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for RLYB hit a ceiling of $1.6 million in Q2 2025 and a floor of -$3.6 million in Q1 2023.
  • Historically, Change in Accured Expenses has averaged -$494666.7 across 3 years, with a median of -$158500.0 in 2025.
  • Biggest five-year swings in Change in Accured Expenses: crashed 316.01% in 2024 and later soared 2796.43% in 2025.
  • Tracing RLYB's Change in Accured Expenses over 3 years: stood at -$687000.0 in 2023, then plummeted by 102.77% to -$1.4 million in 2024, then surged by 102.37% to $33000.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for RLYB at $33000.0 in Q4 2025, -$350000.0 in Q3 2025, and $1.6 million in Q2 2025.